Age Related Maculopathy
5
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
6 treatments under study, led by Module 2 Control Of Reading Eye Movements
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (5)
The Role of Macular Pigment in Patients With Age-related Macular Degeneration
A Multi-Center Study of Reading Rehabilitation in Macular Disease
Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation for Two More Years (LUTEGA 2)
Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation on Optical Density of AMD Patients (LUTEGA)
Measuring Reading Rehabilitation Outcomes
Research Network
Common Treatments
- Module 2 Control Of Reading Eye Movements1
- Eccentric Viewing Training For Reading1
- Lutein Zeaxanthin Omega3fa1
- Module 3 Reading Practice With Rsvp1
- Lutein Zeaxanthin Omega 3 Fatty Acids1
Active Sponsors
- University of Jena2
- US Department of Veterans Affairs2
- Insel Gruppe AG, University Hospital Bern1
Top Investigators
University Hospital, Jena
Research & Development Service 151, Jesse Brown VA Medical Center
Jesse Brown VAMC (WestSide Division)
University Hospital Jena
University Hospital, Jena
Related Conditions
- Retinal Degeneration2